We are live on ! Find out more
CEP

Chicago Equity Partners Portfolio holdings

AUM $993M
1-Year Est. Return 6.42%
This Fund
S&P 500
This Quarter Est. Return
+5.41%
1 Year Est. Return
-6.42%
3 Year Est. Return
+34.83%
5 Year Est. Return
+90.28%
10 Year Est. Return
AUM
$3.63B
AUM Growth
+$297M
Cap. Flow
+$186M
Cap. Flow %
5.12%
Top 10 Hldgs %
16.99%
Holding
521
New
107
Increased
188
Reduced
135
Closed
77

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$41.7M
2
STJ
St Jude Medical
STJ
+$28.9M
3
C icon
Citigroup
C
+$27.7M
4
AES icon
AES
AES
+$22.8M
5
NFLX icon
Netflix
NFLX
+$21.9M

Sector Composition

Rank Sector Weight
1 Financials 16.21%
2 Industrials 13.73%
3 Healthcare 12.86%
4 Technology 10.89%
5 Energy 9.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EAT icon
151
Brinker International
EAT
$8.02B
$5.55M 0.15%
+105,790
New +$5.29M
AVY icon
152
Avery Dennison
AVY
$12.3B
$5.52M 0.15%
108,940
-8,610
-7% -$430K
SM icon
153
SM Energy
SM
$7.96B
$5.3M 0.15%
74,365
-244,840
-77% -$19.2M
IT icon
154
Gartner
IT
$9.41B
$5.29M 0.15%
76,160
+2,000
+3% +$138K
GAS
155
DELISTED
AGL Resources Inc
GAS
$5.05M 0.14%
+103,075
New +$4.86M
AIG icon
156
American International
AIG
$41.9B
$4.77M 0.13%
95,375
+43,675
+84% +$2.17M
ADVS
157
DELISTED
Advent Software Inc
ADVS
$4.67M 0.13%
159,180
+16,650
+12% +$531K
DNY
158
DELISTED
DONNELLEY R R & SONS CO
DNY
$4.47M 0.12%
249,640
+4,700
+2% +$84.1K
CRL icon
159
Charles River Laboratories
CRL
$10.9B
$4.44M 0.12%
73,640
+13,200
+22% +$769K
WOR icon
160
Worthington Enterprises
WOR
$2.76B
$4.26M 0.12%
180,894
+11,395
+7% +$284K
BKNG icon
161
Booking.com
BKNG
$138B
$4.06M 0.11%
85,250
-103,775
-55% -$5.12M
CHK
162
DELISTED
Chesapeake Energy Corporation
CHK
$4.05M 0.11%
837
-266
-24% -$1.3M
CMA
163
DELISTED
Comerica
CMA
$4.02M 0.11%
77,585
-74,510
-49% -$3.58M
MPC icon
164
Marathon Petroleum
MPC
$90.3B
$3.97M 0.11%
+91,220
New +$4M
SMG icon
165
ScottsMiracle-Gro
SMG
$4.03B
$3.86M 0.11%
63,020
+50,625
+408% +$3.01M
AET
166
DELISTED
Aetna Inc
AET
$3.79M 0.1%
50,570
-25,375
-33% -$1.8M
EPR icon
167
EPR Properties
EPR
$4.86B
$3.67M 0.1%
68,825
+2,000
+3% +$103K
LEA icon
168
Lear
LEA
$7.19B
$3.62M 0.1%
43,295
-43,230
-50% -$3.44M
AGN
169
DELISTED
Allergan plc
AGN
$3.62M 0.1%
17,590
+4,165
+31% +$825K
XLS
170
DELISTED
EXELIS INC COM STK
XLS
$3.52M 0.1%
198,215
+6,104
+3% +$113K
PPC icon
171
Pilgrim's Pride
PPC
$6.82B
$3.41M 0.09%
162,880
+12,185
+8% +$210K
ZBRA icon
172
Zebra Technologies
ZBRA
$12.4B
$3.4M 0.09%
49,060
-18,925
-28% -$1.16M
SWKS icon
173
Skyworks Solutions
SWKS
$9.06B
$3.4M 0.09%
90,540
+3,000
+3% +$98.6K
WR
174
DELISTED
Westar Energy Inc
WR
$3.31M 0.09%
94,155
+3,500
+4% +$118K
ARR
175
Armour Residential REIT
ARR
$2.02B
$3.26M 0.09%
+19,806
New +$3.32M

Similar funds

Chicago Equity Partners's Q1 2014 Portfolio in Review

As of Q1 2014, Chicago Equity Partners held 521 positions worth $3.63B, up 8.9% from $3.33B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Chicago Equity Partners deployed $186M of net new capital in Q1 2014, opening 107 new positions and adding to 188 existing holdings. Its largest new stake was Gilead Sciences: 530,865 shares worth $37.6M.

By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Amgen, an estimated $41.7M trimmed.

  • Chicago Equity Partners's largest Q1 2014 buy was Gilead Sciences: 530,865 shares worth $37.6M.
  • Chicago Equity Partners added most to Pitney Bowes in Q1 2014, an estimated $34.5M increase.
  • Chicago Equity Partners's biggest Q1 2014 reduction was Amgen, cutting an estimated $41.7M.
  • Chicago Equity Partners fully exited AES in Q1 2014, selling an estimated $22.8M.
  • Chicago Equity Partners's ten largest holdings make up 17% of its $3.63B portfolio in Q1 2014.
  • Chicago Equity Partners opened 107 new positions and closed 77 in Q1 2014.
  • Chicago Equity Partners's portfolio value rose 8.9% quarter-over-quarter to $3.63B.

Based on Chicago Equity Partners's 13F filing for Q1 2014, filed 2 May 2014.